UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 7500 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules and no major patient expiration in the next decade; - More than 25% of 2015 revenue reinvested into Research & Development - 2015 Key Financials: €3.88B global revenue Specialties: Neurology, Immunology
Anderlecht, BE
Size (employees)
7,563 (est)
UCB was founded in 1928 and is headquartered in Anderlecht, BE

UCB Office Locations

UCB has office in Anderlecht
Anderlecht, BE

UCB Metrics

UCB Summary

Market capitalization

$14.6 b

Closing share price

UCB's current market capitalization is $14.6 b.

UCB Market Value History

UCB Online Presence

UCB News

UCB Company Life

You may also be interested in